The FDA said last week that bebtelovimab, a monoclonal antibody drug given through a vein, is no longer authorized because it is not effective against the leading strains of COVID-19.
Dec. 4, 2022 – The number of medications available to treat COVID-19 continues to get smaller as the coronavirus changes to outsmart treatments. The FDA said last week that bebtelovimab, a monoclonal antibody drug given through a vein, isBebtelovimab, made by Eli Lilly, was the last remaining monoclonal antibody treatment of six that had been authorized for emergency use during the pandemic.
Bebtelovimab is not effective against the current primary coronavirus strains of BQ.1 and BQ.1.1. Combined, the two strains account for about 63% of all cases nationwide, according toThe FDA announcement stated that antiviral treatments, including remdesivir, Paxlovid, and Lagevrio, are all still options for patients at high risk for a severe case of COVID-19.
COVID-19 is on the rise nationwide, with hospitalizations averaging more than 35,000 per day. This is a 26% increase over the past two weeks, according to“Cases, hospitalizations and test positivity are all rising at the national level, suggesting that the relative stability seen this fall could be coming to an end,” thesummarized. “Daily case and death data are subject to fluctuations around Thanksgiving that do not affect other metrics.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA Announces Monoclonal Antibody Not Authorized Due to Inability to Fight OmicronA year after the omicron variant of COVID-19 began to upend the world and start a new stage of the pandemic, several new subvariants have originated from the variant, with reaction to treatment changing along with the subvariants.
Lire la suite »
China reports 2 new COVID deaths as some restrictions easedChina on Sunday reported two additional deaths from COVID-19 as some cities move cautiously to ease anti-pandemic restrictions amid increasingly vocal public frustration over the measures.
Lire la suite »
Fintech companies acted with 'inexcusable misconduct,' failed to stop COVID fraud, top Dem allegesFinancial technology services companies received billions of dollars through taxpayer-funded PPP loan processing fees with little oversight of who was getting the loans, House lawmakers allege.
Lire la suite »
LA County posts 4,700 more COVID cases as infections continue to riseAccording to state figures, there were 1,171 COVID-positive patients in county hospitals as of Friday, up from 1,164 a day earlier. Of those patients, 131 were being treated in intensive care units…
Lire la suite »
Wolff: COVID lurks; stay vigilant by getting boostedDespite high initial COVID vaccination rates, interest has faltered. Few people are taking...
Lire la suite »